Article
Efficacy and Safety of BBETTER PsoriaUrja in the Management of Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Trial Protocol
2026-05-26
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Psoriasis is a chronic immune-mediated inflammatory skin disorder characterized by keratinocyte hyperproliferation, systemic inflammation, and dysregulated immune responses. Conventional therapies—including corticosteroids, systemic immunosuppressants, and biologics—are effective but often associated with long-term safety concerns and high treatment burden. B...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f4f5b28-9242-5512-979c-87a8be3c01d9
- DOI
- 10.21203/rs.3.rs-9799148/v1